{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:33:07Z","timestamp":1795015987501,"version":"4.10.1"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Traumatic brain injury (TBI) is a leading cause of trauma-related deaths, and pharmacologic interventions to limit intracranial bleeding should improve outcomes. Tranexamic acid reduces mortality in injured patients with major systemic bleeding, but the effects of antifibrinolytic drugs on outcomes after TBI are less clear. We therefore summarize recent evidence to guide clinicians on when (not) to use antifibrinolytic drugs in TBI patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Tranexamic acid is the only antifibrinolytic drug that has been studied in patients with TBI. Several recent studies failed to conclusively demonstrate a benefit on survival or neurologic outcome. A large trial with more than 12\u200a000 patients found no significant effect of tranexamic acid on head-injury related death, all-cause mortality or disability across the overall study population, but observed benefit in patients with mild to moderate TBI. Observational evidence signals potential harm in patients with isolated severe TBI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Given that the effect of tranexamic acid likely depends on a variety of factors, it is unlikely that a \u2018one size fits all\u2019 approach of administering antifibrinolytics to all patients will be helpful. Tranexamic acid should be strongly considered in patients with mild to moderate TBI and should be avoided in isolated severe TBI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000001171","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T09:18:57Z","timestamp":1659086337000},"page":"583-592","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Antifibrinolytics in the treatment of traumatic brain injury"],"prefix":"10.1097","volume":"35","author":[{"given":"Patrick","family":"Schober","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"Loer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar A.","family":"Schwarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"R2-20250601","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.injury.2016.10.037","article-title":"Trends in 1029 trauma deaths at a level 1 trauma center: impact of a bleeding control bundle of care","volume":"48","author":"Oyeniyi","year":"2017","journal-title":"Injury"},{"key":"R3-20250601","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-227X-9-15","article-title":"Intracranial bleeding in patients with traumatic brain injury: a prognostic study","volume":"9","author":"Perel","year":"2009","journal-title":"BMC Emerg Med"},{"key":"R4-20250601","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/EJA.0000000000001632","article-title":"Efficacy and safety of aprotinin in paediatric cardiac surgery: a systematic review and meta-analysis","volume":"39","author":"Atasever","year":"2022","journal-title":"Eur J Anaesthesiol"},{"key":"R5-20250601","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ajog.2021.09.025","article-title":"Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis","volume":"226","author":"Bellos","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250601","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ejh.13348","article-title":"The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients","volume":"104","author":"Cai","year":"2020","journal-title":"Eur J Haematol"},{"key":"R7-20250601","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/0018578720906613","article-title":"The role of tranexamic acid in the management of an acutely hemorrhaging patient","volume":"56","author":"Davis","year":"2021","journal-title":"Hosp Pharm"},{"key":"R8-20250601","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aas.13981","article-title":"Tranexamic acid for prevention of bleeding in cesarean delivery: an overview of systematic reviews","volume":"66","author":"Hurskainen","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"R9-20250601","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jor.2019.06.025","article-title":"Reducing perioperative blood loss with antifibrinolytics and antifibrinolytic-like agents for patients undergoing total hip and total knee arthroplasty","volume":"16","author":"Kapadia","year":"2019","journal-title":"J Orthop"},{"key":"R10-20250601","doi-asserted-by":"crossref","first-page":"103271","DOI":"10.1016\/j.otsr.2022.103271","article-title":"The effect of antifibrinolytic agents in periacetabular osteotomy: a systematic review and meta-analysis","volume":"108","author":"Kim","year":"2022","journal-title":"Orthop Traumatol Surg Res"},{"key":"R11-20250601","doi-asserted-by":"crossref","first-page":"zrab004","DOI":"10.1093\/bjsopen\/zrab004","article-title":"Safety and efficacy of tranexamic acid in minimizing perioperative bleeding in extrahepatic abdominal surgery: meta-analysis","volume":"5","author":"Koh","year":"2021","journal-title":"BJS Open"},{"key":"R12-20250601","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/ans.16909","article-title":"Antifibrinolytics reduces blood loss in thoracic surgery: a systematic review and meta-analysis","volume":"91","author":"Leow","year":"2021","journal-title":"ANZ J Surg"},{"key":"R13-20250601","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery","volume":"386","author":"Devereaux","year":"2022","journal-title":"N Engl J Med"},{"key":"R14-20250601","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"R15-20250601","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jamaneurol.2020.4596","article-title":"Association between prehospital tranexamic acid administration and outcomes of severe traumatic brain injury","volume":"78","author":"Bossers","year":"2021","journal-title":"JAMA Neurol"},{"key":"R16-20250601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2022.02.029","article-title":"The role of tranexamic acid in traumatic brain injury","volume":"99","author":"Honeybul","year":"2022","journal-title":"J Clin Neurosci"},{"issue":"(Suppl 1)","key":"R17-20250601","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/MBC.0000000000001099","article-title":"The physiology of hemostasis","volume":"33","author":"Sierra","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R18-20250601","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"key":"R19-20250601","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s12276-020-0397-x","article-title":"Therapeutics targeting the fibrinolytic system","volume":"52","author":"Lin","year":"2020","journal-title":"Exp Mol Med"},{"key":"R20-20250601","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1097\/HS9.0000000000000570","article-title":"The fibrinolytic system: mysteries and opportunities","volume":"5","author":"Medcalf","year":"2021","journal-title":"Hemasphere"},{"key":"R21-20250601","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R22-20250601","first-page":"16","article-title":"Trauma-induced coagulopathy: overview of an emerging medical problem from pathophysiology to outcomes","volume":"8","author":"Savioli","year":"2021","journal-title":"Medicines (Basel)"},{"key":"R23-20250601","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0041-1722970","article-title":"Fibrinolysis in traumatic brain injury: diagnosis, management, and clinical considerations","volume":"47","author":"Anderson","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"R24-20250601","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0040-1702178","article-title":"Changes in coagulation following brain injury","volume":"46","author":"Maegele","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"R25-20250601","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jss.2016.06.023","article-title":"Relationship between tissue perfusion and coagulopathy in traumatic brain injury","volume":"205","author":"Dekker","year":"2016","journal-title":"J Surg Res"},{"key":"R26-20250601","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0036-1586227","article-title":"Plasmin: a modulator of immune function","volume":"43","author":"Draxler","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"R27-20250601","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1213\/ANE.0000000000004389","article-title":"Tranexamic acid for acute hemorrhage: a narrative review of landmark studies and a critical reappraisal of its use over the last decade","volume":"129","author":"Lier","year":"2019","journal-title":"Anesth Analg"},{"key":"R28-20250601","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4103\/1673-5374.284979","article-title":"Using antifibrinolytics to tackle neuroinflammation","volume":"15","author":"Atsev","year":"2020","journal-title":"Neural Regen Res"},{"key":"R29-20250601","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.14972","article-title":"Adjunctive treatment for acne vulgaris by tranexamic acid","author":"Charoenwattanayothin","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R30-20250601","article-title":"The uses of tranexamic acid in dermatology: a review","author":"Kim","journal-title":"Int J Dermatol"},{"key":"R31-20250601","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/aca.ACA_205_18","article-title":"Antifibrinolytics and cardiac surgery: the past, the present, and the future","volume":"23","author":"Aggarwal","year":"2020","journal-title":"Ann Card Anaesth"},{"key":"R32-20250601","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jtcvs.2007.12.025","article-title":"Aprotinin and cardiac surgery","volume":"135","author":"DeAnda","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R33-20250601","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2165\/00003495-199549060-00008","article-title":"Aprotinin: a review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery","volume":"49","author":"Davis","year":"1995","journal-title":"Drugs"},{"key":"R34-20250601","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"R35-20250601","doi-asserted-by":"crossref","first-page":"e12546","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"R36-20250601","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bja.2020.07.058","article-title":"Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial","volume":"126","author":"Grassin-Delyle","year":"2021","journal-title":"Br J Anaesth"},{"key":"R37-20250601","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bja.2020.10.003","article-title":"Intramuscular tranexamic acid: a real-world application of pharmacokinetics","volume":"126","author":"Cortegiani","year":"2021","journal-title":"Br J Anaesth"},{"key":"R38-20250601","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jcp.33.Suppl_14.41","article-title":"Clinical pharmacology of aminocaproic and tranexamic acids","volume":"14","author":"Nilsson","year":"1980","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"key":"R39-20250601","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/bja\/aet154","article-title":"Antifibrinolytic agents in current anaesthetic practice","volume":"111","author":"Ortmann","year":"2013","journal-title":"Br J Anaesth"},{"key":"R40-20250601","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/TA.0b013e318292cc54","article-title":"Tranexamic acid in trauma: how should we use it?","volume":"74","author":"Napolitano","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R41-20250601","doi-asserted-by":"crossref","first-page":"d3795","DOI":"10.1136\/bmj.d3795","article-title":"Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study)","volume":"343","year":"2011","journal-title":"BMJ"},{"key":"R42-20250601","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"R43-20250601","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"key":"R44-20250601","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1213\/ANE.0000000000004545","article-title":"Adjustments for multiple testing in medical research","volume":"130","author":"Schober","year":"2020","journal-title":"Anesth Analg"},{"key":"R45-20250601","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00134-019-05879-5","article-title":"Is tranexamic acid going to CRASH the management of traumatic brain injury?","volume":"46","author":"Taccone","year":"2020","journal-title":"Intensive Care Med"},{"key":"R46-20250601","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/cem.2020.19","article-title":"Does tranexamic acid reduce traumatic brain injury-related death?","volume":"22","author":"Blanchard","year":"2020","journal-title":"CJEM"},{"key":"R47-20250601","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/acem.14163","article-title":"Tranexamic acid for traumatic brain injury","volume":"28","author":"Long","year":"2021","journal-title":"Acad Emerg Med"},{"key":"R48-20250601","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(20)30546-8","article-title":"Tranexamic acid for traumatic brain injury","volume":"396","author":"Bourn","year":"2020","journal-title":"Lancet"},{"key":"R49-20250601","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(20)30535-3","article-title":"Tranexamic acid for traumatic brain injury","volume":"396","author":"Goursaud","year":"2020","journal-title":"Lancet"},{"key":"R50-20250601","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(20)30536-5","article-title":"Tranexamic acid for traumatic brain injury","volume":"396","author":"Kolias","year":"2020","journal-title":"Lancet"},{"key":"R51-20250601","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(20)30544-4","article-title":"Tranexamic acid for traumatic brain injury","volume":"396","author":"Reynard","year":"2020","journal-title":"Lancet"},{"key":"R52-20250601","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(20)30542-0","article-title":"Tranexamic acid for traumatic brain injury","volume":"396","author":"Schober","year":"2020","journal-title":"Lancet"},{"key":"R53-20250601","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(20)30541-9","article-title":"Tranexamic acid for traumatic brain injury","volume":"396","author":"Solla","year":"2020","journal-title":"Lancet"},{"key":"R54-20250601","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","journal-title":"JAMA"},{"key":"R55-20250601","first-page":"11","article-title":"Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial","volume":"156","author":"Guyette","year":"2021","journal-title":"JAMA Surg"},{"key":"R56-20250601","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","article-title":"Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients","volume":"45","author":"Chakroun-Walha","year":"2019","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R57-20250601","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1574887114666190620112829","article-title":"Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"14","author":"Ebrahimi","year":"2019","journal-title":"Rev Recent Clin Trials"},{"key":"R58-20250601","doi-asserted-by":"crossref","first-page":"e748","DOI":"10.1016\/j.wneu.2017.10.075","article-title":"Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury","volume":"109","author":"Fakharian","year":"2018","journal-title":"World Neurosurg"},{"key":"R59-20250601","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","article-title":"The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial","volume":"20","author":"Jokar","year":"2017","journal-title":"Chin J Traumatol"},{"key":"R60-20250601","first-page":"107","article-title":"The effect of intravenous tranexamic acid on preventing the progress of cerebral hemorrhage in patients with brain traumatic injuries compared to placebo: a randomized clinical trial","volume":"34","author":"Mojallal","year":"2020","journal-title":"Med J Islam Repub Iran"},{"key":"R61-20250601","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574887114666191118111826","article-title":"Intravenous tranexamic acid for brain contusion with intraparenchymal hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"15","author":"Mousavinejad","year":"2020","journal-title":"Rev Recent Clin Trials"},{"key":"R62-20250601","first-page":"223","article-title":"Effect of intravenous tranexamic acid on intracerebral brain hemorrhage in traumatic brain injury","volume":"31","author":"Safari","year":"2021","journal-title":"Turk Neurosurg"},{"key":"R63-20250601","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Yutthakasemsunt","year":"2013","journal-title":"BMC Emerg Med"},{"key":"R64-20250601","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41016-020-00196-z","article-title":"The effect of tranexamic acid in patients with TBI: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Du","year":"2020","journal-title":"Chin Neurosurg J"},{"key":"R65-20250601","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajem.2019.158499","article-title":"The efficacy of tranexamic acid for brain injury: a meta-analysis of randomized controlled trials","volume":"38","author":"Chen","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R66-20250601","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12883-020-01694-4","article-title":"Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury: meta-analysis of randomized controlled trials","volume":"20","author":"July","year":"2020","journal-title":"BMC Neurol"},{"key":"R67-20250601","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40560-020-00460-5","article-title":"Efficacy and safety of tranexamic acid administration in traumatic brain injury patients: a systematic review and meta-analysis","volume":"8","author":"Yokobori","year":"2020","journal-title":"J Intensive Care"},{"key":"R68-20250601","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00134-020-06279-w","article-title":"Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials","volume":"47","author":"Lawati","year":"2021","journal-title":"Intensive Care Med"},{"key":"R69-20250601","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1016\/j.wneu.2019.01.145","article-title":"Improving survival with tranexamic acid in cerebral contusions or traumatic subarachnoid hemorrhage: univariate and Multivariate analysis of independent factors associated with lower mortality","volume":"125","author":"Chan","year":"2019","journal-title":"World Neurosurg"},{"key":"R70-20250601","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/TA.0000000000002269","article-title":"Tranexamic acid administration following head trauma in a combat setting: does tranexamic acid result in improved neurologic outcomes?","volume":"87","author":"Morte","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R71-20250601","first-page":"660","article-title":"Tranexamic acid in traumatic brain injury","volume":"75","author":"Nelson Yap","year":"2020","journal-title":"Med J Malaysia"},{"key":"R72-20250601","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00068-021-01827-5","article-title":"The effect of prehospital tranexamic acid on outcome in polytrauma patients with associated severe brain injury","volume":"48","author":"van Wessem","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R73-20250601","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1213\/ANE.0000000000004627","article-title":"Confounding in observational research","volume":"130","author":"Schober","year":"2020","journal-title":"Anesth Analg"},{"key":"R74-20250601","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.annemergmed.2022.01.045","article-title":"Optimal out-of-hospital blood pressure in major traumatic brain injury: a challenge to the current understanding of hypotension","volume":"80","author":"Spaite","year":"2022","journal-title":"Ann Emerg Med"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:01:20Z","timestamp":1748815280000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001171","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}